111 Inc ADR(YI) 주가 전망 및 기업 분석 - PER·배당·실적·목표주가·RSI·MACD

111 Inc ADR

7월 27일 4:00 PM ET (한국 7/28 05:00)

$3.72

-0.28 ▼ -7.00%

YI is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시가총액

$19M

스몰캡

P/E

배당수익률

없음

52주 위치

14%

저점 +50% · 고점 -67%

애널리스트

적극 매수

Fundamental health

vs. Healthcare 초소형주· based on 2 axes

수익성

산출 불가 (적자)

성장

Top 43%

밸류에이션

데이터 부족

재무 안정

Top 79%

Index ⓘ	-	P/E ⓘ	-	EPS (ttm) ⓘ	-1.39	Insider Own ⓘ	1.82%	Shs Outstand ⓘ	5.2M	Perf Week ⓘ	-1.33%
Market Cap ⓘ	0.02B	Forward P/E ⓘ	-	EPS next Y ⓘ	-	Insider Trans ⓘ	-93.05%	Shs Float ⓘ	5.1M	Perf Month ⓘ	-7%
Enterprise Value ⓘ	0.14B	PEG ⓘ	-	EPS next Q ⓘ	-	Inst Own ⓘ	1.21%	Short Float ⓘ	0.18%	Perf Quarter ⓘ	-45.29%
Income ⓘ	-0.01B	P/S ⓘ	0.01	EPS this Y ⓘ	-	Inst Trans ⓘ	-55.77%	Short Ratio ⓘ	0.41	Perf Half Y ⓘ	-27.49%
Sales ⓘ	1.60B	P/B ⓘ	-	EPS next 5Y ⓘ	-	ROA ⓘ	-3.8%	Short Interest ⓘ	0.01M	Perf YTD ⓘ	45.31%
Book/sh ⓘ	-12.17	P/C ⓘ	0.34	EPS past 3/5Y ⓘ	47.72% 33.28%	ROE ⓘ	-	52W High ⓘ	-66.7% ($11.17)	Perf Year ⓘ	-49.18%
Cash/sh ⓘ	11.06	P/FCF ⓘ	-	Sales past 3/5Y ⓘ	-4.53% 8.01%	ROIC ⓘ	-	52W Low ⓘ	50% ($2.48)	Perf 3Y ⓘ	-87.96%
Dividend Est. ⓘ	-	EV/EBITDA ⓘ	-	EPS Y/Y TTM ⓘ	-25.89%	Gross Margin ⓘ	5.74%	Volatility(W/M) ⓘ	3.43% 7.88%	Perf 5Y ⓘ	-93.36%
Dividend TTM ⓘ	-	EV/Sales ⓘ	0.09	Sales Y/Y TTM ⓘ	-19.75%	Oper. Margin ⓘ	-0.27%	ATR (14) ⓘ	0.34	Perf 10Y ⓘ	-
Dividend Ex-Date ⓘ	-	Quick Ratio ⓘ	0.49	EPS Q/Q ⓘ	-117.06%	Profit Margin ⓘ	-0.76%	RSI (14) ⓘ	41.15	Recom ⓘ	1
Dividend Gr. 3/5Y ⓘ	-	Current Ratio ⓘ	1.08	Sales Q/Q ⓘ	-29.68%	SMA20 ⓘ	-6.23% ($3.97)	Beta ⓘ	0.68	Target Price ⓘ	$12.01
Payout ⓘ	-	Debt/Eq ⓘ	-	Earnings ⓘ	2026/6/4	SMA50 ⓘ	-18.21% ($4.55)	Rel Volume ⓘ	0.08	Prev Close ⓘ	$4
Employees ⓘ	1063	LT Debt/Eq ⓘ	-	EPS/Sales Surpr. ⓘ	-	SMA200 ⓘ	-28.57% ($5.21)	Avg Volume(3M) ⓘ	0.02M	Price ⓘ	$3.72
IPO ⓘ	2018/9/12	Option/Short ⓘ	No/Yes			Trades ⓘ	40	Volume ⓘ	1,780	Change ⓘ	-7%

Quarterly earnings trend Quarterly earnings data is not yet available — foreign-listed companies (ADRs) only file annual reports with the U.S., and recently listed companies may not have filed their first quarterly report.

📊 111 Inc ADR (YI) Investment Analysis

What kind of company is 111 Inc ADR?

111 Inc ADR (YI) 방어주

Healthcare · Medical Distribution

Small-Cap — Low Volume, High Volatility

111 is a Chinese digital healthcare and pharmaceutical distribution company that operates its own B2C online pharmacy, "1 Drugstore," and a B2B pharmacy wholesale platform, "1 Drugmall." Its core strategy is to build a direct supply chain for small pharmacies and hospitals, connecting China's pharmaceutical distribution through an integrated online and offline model.

Learn more about 111 Inc ADR →

Market Cap

$0.0B

Approx. KRW 0.0 trillion

⚖️ 0% of Samsung Electronics

Market Cap Rank5279

Employees1,063people

IPO2018/09/12

Current Price$3.72 ≈ 5,096원

NASD · China

Key Events

⏰ Upcoming events

🔔 Earnings release

The next release date has not been announced yet.

🎯 Ex-dividend date

No scheduled dividends

📜 Recent events

🔔 Earnings release 2026년 6월 4일 (목) · 장 마감 후

🔔 Earnings release 2026년 4월 9일 (목) · 장 시작 전

Is it profitable?

Profitability weak

Profitability — How efficiently it makes money

Operating Margin

Profit kept from selling products and services (higher is better)

-0.3%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Net Margin

Share of revenue left after taxes and interest are paid

-0.8%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Gross Margin

Profit after subtracting raw-material costs only (signals product competitiveness)

5.7%

✓ 평균

My positionMid-range

Low range Average High range

Healthcare 초소형주 Median 42.6% · Bottom 25%

💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)

ROA

Annual earnings relative to total company assets

-3.8%

✓ 적자

💡 적자 상태 — 수익을 내지 못하고 있습니다

Financial health — Debt & liquidity burden

Current Ratio

Liquid assets available to cover liabilities due within a year

1.08

✓ 평균

My positionMid-range

Low range Average High range

Healthcare 초소형주 Median 2.76

💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의

Quick Ratio

Liquid assets excluding inventory, available for immediate use

0.49

✓ 부진

My positionBottom 25%

Low range Average High range

Healthcare 초소형주 Median 2.54

💡 1.0 이상이면 안전, 0.5 미만이면 주의

* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook

Positive and negative signals are mixed

애널리스트 목표가

$12.01

현재가 대비 +222.8%

💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균

⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Insufficient historical earnings data

No analyzable past earnings releases have been collected yet.

Is it growing?

Average Growth

Mid-range within the industry

Healthy, Balanced Growth EPS and revenue are both growing steadily — a sustainable growth profile

📊 How much has it grown? (actual results)

Past 3-Year EPS

Actual average annual EPS growth over the past 3 years

+47.7%

양호

My positionMid-range

Low range Average High range

방어주 초소형주 Median 30.0% · Top 36%

Past 5-Year EPS

Actual average annual EPS growth over the past 5 years

+33.3%

양호

My positionMid-range

Low range Average High range

방어주 초소형주 Median 16.4% · Top 35%

Past 5-Year Revenue

How much revenue grew over the past 5 years

+8.0%

양호

My positionMid-range

Low range Average High range

방어주 초소형주 Median 2.1% · Top 30%

⚡ Short-term momentum

QoQ Revenue

Revenue change from the previous quarter (short-term momentum)

-29.7%

평균

My positionMid-range

Low range Average High range

방어주 초소형주 Median -4.5% · Bottom 28%

* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -162%p below the market

YI -93.4% · S&P 500 +68.3%

Excess return vs. market (price-based, ex-dividends)

5-year basis

vs S&P 500

-161.7%p

Significantly behind the market

vs Health Care (XLV)

-117.9%p

Significantly behind the sector average

1-year basis

vs S&P 500

-65.2%p

Significantly behind the market

vs Health Care (XLV)

-68.9%p

Significantly behind the sector average

Current position within 52-week range

Low (-50.0%p) High (-66.7%p)

Current price is 50.0% above the 52-week low and 66.7% below the 52-week high

Recent risk (last 120 trading days)

Max drawdown

-56.7%

Annualized volatility

70.1%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

close
BB Upper
BB Mid
BB Lower
Tenkan
Kijun
Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴

Current diagnosis · 2026-07-27

Downtrend zone

Current price $3.72 below the midline ($3.96). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟡

Current diagnosis · 2026-07-27

Neutral zone — weak trend

MACD -0.200 · Signal -0.240 · Hist 0.041. Weak directional bias.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴

Current diagnosis · 2026-07-27

Bearish zone

RSI 40.4 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 20.5.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry

Cheap on Vs. Sales

💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.

🧾 Vs. Sales Cheap

🧾 Vs. Sales

PSR Price-to-Sales Ratio

Market cap vs. revenue — lower is cheaper relative to sales

0.01x

✓ Very cheap

My positionTop 5%

Low range Average High range

Healthcare 초소형주 median 3.22x · Top 1% — relatively cheap within the industry

💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)

Analyst target price (reference)

$12.01 vs. current price +222.8%

* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.

As of: Recent snapshot · Peer group: Healthcare 초소형주

Who owns it?

Ownership backdrop is unfavorable

Insider net selling -93.0% · Institutional net selling -55.8% · Short interest light 0.2%

📈 Recent trading flow (6 months)

🧑‍💼 Insiders (executives & directors)

-93.0%

Insiders large net selling

🏦 Institutions (funds & investors)

-55.8%

Institutions large net selling

💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.

👥 Holdings composition

🏦 Institutions 1.2%

Retail-led

Healthcare 초소형주 Median 14.2%

🧑‍💼 Insiders 1.8%

Typical level

Healthcare 초소형주 Median 16.1%

👤 Retail investors (estimated) 97.0%

Everyone excluding institutions and insiders

Institutions Insiders Retail (est.)

📉 Short-selling metrics

Short ratio

0.2%

Low — limited short-side pressure

Healthcare 초소형주 Median 3.9%

Past 89 days Little change

Short interest days to cover

0.4 days

Days needed to close short positions using average trading volume

🧮 Share count

Total shares outstanding 5.2M주

Float (tradable shares) 5.1M주

* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 89 days.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)

Sorted by market cap, largest first

Stock	Market Cap	PER	PBR	ROE	Dividend Yield	Change
YI This Stock	$19.3M	-	-	-	-	-7.0%
LLY	$1.13T	43.1 ▼	36.2 ▼	107.64% ▲	0.58% ▼	+0.1%
JNJ	$640.9B	30.8 ▼	7.5 ▼	25.74% ▲	2.02% ▲	+1.0%
ABBV	$453.9B	126.7 ▼	-	15221.82% ▲	2.67% ▲	-0.9%
UNH	$379.3B	26.9 ▼	3.9 ▼	12.49% ▲	2.16% ▲	-0.7%
MRK	$323.0B	36.8 ▼	7.0 ▼	18.97% ▲	2.5% ▲	-0.2%
Sector Avg	-	26.1	2.7	-48.83%	1.23%	-

Derivative ETFs for YI

Leveraged, inverse, and covered call ETFs based on the underlying asset

6 derivative ETFs based on YI (Leverage 1 · Inverse 1 · Covered Call 4)

These are based on the same underlying asset but carry a completely different risk and return profile. Please review the warning below first.

ℹ️ What is a Derivative ETF?

These are special ETFs that amplify, reverse, or monetize the price movement of an underlying ETF or security. Leveraged ETFs aim for 2–3× the daily move, Inverse ETFs target opposite-direction returns, and Covered Call ETFs generate monthly income from option premiums.

⚠️ Caution: Long-Term Holding

Leveraged and inverse ETFs track only the daily return. With high volatility, holding them for longer periods causes cumulative volatility decay—returns diverge further from the underlying index. They are meant for short-term trading.

📈 Leverage 1 ETFs that move 2-3x with YI (high volatility)